Vicki L. Sato - 18 Jun 2025 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/Earl Douglas, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
18 Jun 2025
Net transactions value
$0
Form type
4
Filing time
23 Jun 2025, 21:04:04 UTC
Previous filing
02 Jun 2025
Next filing
02 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SATO VICKI L Director 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO /s/Earl Douglas, Attorney-in-Fact 20 Jun 2025 0001197020

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to buy) Award $0 +144,400 $0.000000 144,400 18 Jun 2025 Common Stock 144,400 $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting in 12 equal monthly installments.

Remarks:

Exhibits: Power of Attorney